Division of Hematology and Oncology Archive — Page 9 of 15
-
February 5, 2020
Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform
Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform. -
January 9, 2020
Park named interim Hematology and Oncology director
Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology. -
December 5, 2019
Balko lands Mary Kay Foundation grant for breast cancer research
Vanderbilt-Ingram Cancer Center's Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation. -
December 4, 2019
Genetic screen in worms reveals critical step in insulin synthesis
The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes. -
November 6, 2019
Rathmell receives 2019 Eugene P. Schonfeld Award
The Kidney Cancer Association is recognizing the research accomplishments and leadership achievements of W. Kimryn Rathmell, MD, PhD, with its top honor, the Eugene P. Schonfeld Award. -
November 1, 2019
New Physician Spotlight: Cathy Eng
Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, was recruited to VUMC from The University of Texas MD Anderson Cancer Center in Houston. -
October 3, 2019
VICC’s Rathmell honored with Louisa Nelson Award
Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology, received an award that honors women who embody the achievement, vision and inspiration of the founder of a local distillery.